BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15609914)

  • 1. [Role of cardiac resynchronisation in the treatment of cardiac failure].
    Leclercq C; Crocq C; Mabo P; Daubert C
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1116-21. PubMed ID: 15609914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G; Ricci R; Cacciatore G; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Implantable defibrillator and ventricular resynchronisation].
    Jego C; Deharo JC
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1122-9. PubMed ID: 15609915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biventicular pacing in patients with severe heart failure].
    Merkely B; Vágó H; Bartha E; Zima E; Moravcsik E; Gellér L
    Orv Hetil; 2001 Dec; 142(51):2835-40. PubMed ID: 11828932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The best of cardiac pacing in 2004].
    Chauvin M
    Arch Mal Coeur Vaiss; 2005 Jan; 98 Spec No 1():63-7. PubMed ID: 15714866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing trials of cardiac resynchronisation.
    Cleland JG; Ghosh J; Khan N; Hurren S; Kaye G
    Minerva Cardioangiol; 2003 Apr; 51(2):197-207. PubMed ID: 12783075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac resynchronization for heart failure: background, methods, indications and results].
    Hernández Madrid A; Escobar Cervantes C; Blanco Tirado B; Marín Marín I; Moya Mur JL; Moro C
    Rev Esp Cardiol; 2004 Jul; 57(7):680-93. PubMed ID: 15274853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy].
    van Gelder IC; Smit MD; Nieuwland W; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2238-44. PubMed ID: 17076357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac resynchronisation therapy as a cause of the electrical storm].
    Krupa W; Lackowski J; Sielski S; Dobosiewicz R; Kubica J
    Kardiol Pol; 2007 Nov; 65(11):1350-3. PubMed ID: 18058584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study.
    Leclercq C; Cazeau S; Lellouche D; Fossati F; Anselme F; Davy JM; Sadoul N; Klug D; Mollo L; Daubert JC
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S23-30. PubMed ID: 17302711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The best of cardiac pacing in 2005].
    Chauvin M
    Arch Mal Coeur Vaiss; 2006 Jan; 99 Spec No 1(1):79-84. PubMed ID: 16479968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronisation therapy for heart failure.
    Behan MW; Rinaldi CA
    Int J Clin Pract; 2006 Sep; 60(9):1107-14. PubMed ID: 16939553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE).
    Kindermann M; Hennen B; Jung J; Geisel J; Böhm M; Fröhlig G
    J Am Coll Cardiol; 2006 May; 47(10):1927-37. PubMed ID: 16697307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC.
    Salukhe TV; Dimopoulos K; Francis D
    Int J Cardiol; 2004 Feb; 93(2-3):101-3. PubMed ID: 14975534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.
    Ellery S; Williams L; Frenneaux M
    Postgrad Med J; 2006 Jan; 82(963):16-23. PubMed ID: 16397075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.